ESMO Sarcoma and Rare Cancers 2023 | ESMO Sarcoma and Rare Cancers 2023 highlights: rare cancers at the forefront

Robin Jones, MBBS, MRCP, MD, The Royal Marsden Hospital, London, UK, comments on his main highlights from ESMO 2023 including the plethora of cross cutting sessions that were applicable to all rare cancer types. Some of the presentations Prof Jones notes as conference highpoints include those on tumor agnostic oncology, health technology assessments and the use of real-world data in rare cancers. This interview took place at the ESMO Sarcoma and Rare Cancers Congress 2023 in Lugano, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.